Prostate Cancer
A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy - Abstract
September 20, 2011
Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade - Abstract
September 19, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody - Abstract
September 19, 2011
Heregulin expression and prognosis in prostate adenocarcinoma - Abstract
September 19, 2011
Dietary acrylamide and risk of prostate cancer - Abstract
September 19, 2011
Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: A case report - Abstract
September 19, 2011
Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men - Abstract
September 19, 2011
Genetics may explain why calcium increases risk for prostate cancer
September 19, 2011
Prostate cancer can be detected even in patients with decreased PSA less than 2.5 ng/ml after treatment of chronic prostatitis - Abstract
September 16, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract
September 16, 2011
Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract
September 16, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy - Abstract
September 16, 2011
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract
September 16, 2011